Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas
| Autor: | Song, Y., Yoon, D.H., Yang, H., Cao, J., Ji, D., Koh, Y., Jing, H., Eom, H., Kwak, J., Lee, W., Lee, J., Shin, H., Jin, J., Wang, M., Yang, Z., Kim, W.S., Zhu, J. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34(11):1055-1063 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|